Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3215-3222

  Galassi, Andrea ^a   Spiegel, David M ^b   Bellasi, Antonio ^a,c   Block, Geoffrey A ^d   Raggi, Paolo ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF COLORADO   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Denver Nephrology   (United States)

Author keywords

Calcium salt; Coronary artery calcium; Diabetes mellitus; Phosphate binders; Vascular calcification

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; CALCIUM SALT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; VITAMIN D; WARFARIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; ELECTRON BEAM TOMOGRAPHY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERCHOLESTEROLEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOPARATHYROIDISM; INTERSTITIAL NEPHRITIS; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ACETATES; CALCINOSIS; CALCIUM; CALCIUM CARBONATE; CALCIUM COMPOUNDS; CORONARY VESSELS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHORUS; POLYAMINES; RENAL DIALYSIS;

EID: 33750000098     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl395     Document Type: Article

References (40)

1. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in haemodialysis patients. Kidney Int 2002; 62: 245-252
2. Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to haemodialysis. Kidney Int 2005; 68: 1815-1824
3. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC. Progression of aortic calcification is associated with metacarpal bone loss during menopause: A population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000; 20: 1926-1931
4. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951
5. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 12: S16-S23
6. Malluche HH, Mawad H, Monier-Faugere MC. The importance of bone health in end-stage renal disease: Out of the frying pan, into the fire? Nephrol Dial Transplant 2004; 19: I9-i13
7. Kurz P, Monier-Faugere MC, Bognar B et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46: 855-861
8. Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int 1993; 43: 436-442
9. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
10. Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942
11. Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol 2003; 14: 159-168
12. Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJD. Total hip bone mass predicts survival in chronic haemodialysis patients. Kidney Int 2003; 63: 1116-1120
13. Nishizawa Y, Morii H. Osteoporosis and atherosclerosis in chronic renal failure. Osteoporosis Int 1997; 3: S188-S192
14. Massry S. K/DOQI guidelines released on bone metabolism and disease in CKD. Nephrol News Issues 2003; 17: 38-41
15. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832
16. Achenbach S, Ropers D, Mohlenkamp S et al. Variability of repeated coronary artery calcium measurements by electron beam tomography. Am J Cardiol 2001; 87: 210-213
17. Demer LL, Tintut Y. Mineral exploration: Search for the mechanism of vascular calcification and beyond: The 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 2003; 23: 1739-1743
18. Abedin M, Tintut Y, Demer LL. Mesenchymal stem cells and the artery wall. Circ Res 2004; 95: 671-676
19. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993; 91: 1800-1809
20. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994; 94: 1597-1604
21. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994; 93: 2393-2402
22. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-2176
23. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17
24. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995; 15: 2003-2009
25. Bellows CG, Aubin JE, Heersche JN. Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 1991; 14: 27-40
26. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867
27. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332: 305-311
28. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95: 1046-1057
29. van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001; 103: 255-261
30. Sodhi CP, Phadke SA, Batlle D, Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 2001; 50: 1482-1490
31. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 2001; 28: 195-201
32. Miyata T, Notoya K, Yoshida K et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 1997; 8: 260-270
33. Reid IR, Evans MC, Cooper GJ, Ames RW, Stapleton J. Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 1993; 265: E655-E659
34. Takemoto M, Yokote K, Yamazaki M et al. Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1999; 258: 722-726
35. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE. Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population-based study. Calcif Tissue Int 1996; 59: 352-356
36. Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000; 3: 433-438
37. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 2001; 16: 182-188
38. Inaba M, Nagasue K, Okuno S et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 2002; 39: 1261-1269
39. Raggi P, James G, Burke SK et al. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in haemodialysis. J Bone Miner Res 2005; 20: 764-772
40. Hesch RD, Brabant G, Rittinghaus EF, Atkinson MJ, Harms H. Pulsatile secretion of parathyroid hormone and its action on a type I and type II PTH receptor: A hypothesis for understanding osteoporosis. Calcif Tissue Int 1998; 42: 341-344